Ruconest

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2011-2018
01220112018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Acute treatment of hereditary angioedema due to C1 inhibitor deficiency has become available in the last 10 years and has greatly… (More)
Is this relevant?
2016
2016
process and by the low yields obtained from those animals that were successfully modified. Despite subsequent improvements in… (More)
  • table 1
Is this relevant?
2015
2015
Conestat alfa (Ruconest): first recombinant C1 esterase inhibitor for the treatment of acute attacks in patients with hereditary… (More)
Is this relevant?
Review
2015
Review
2015
Hereditary angioedema is a rare genetic condition transmitted as an autosomal dominant trait and characterized most commonly by… (More)
Is this relevant?
2014
2014
BACKGROUND For safe and efficacious treatment of hereditary angioedema, C1 esterase inhibitor (C1-INH) concentrates should have… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2014
2014
BACKGROUND Conestat alfa (Ruconest, rhC1INH) is the first recombinant human C1 inhibitor protein (C1INH) for the treatment of… (More)
Is this relevant?
Review
2011
Review
2011
To the Editor: We read with great interest the excellent review on the role of immunity and inflammation in acute ischemic stroke… (More)
Is this relevant?